Alterity Therapeutics Limited

ASX (AUD): Alterity Therapeutics Limited (ATH)

Last Price

0.01

Today's Change

0.00 (0.00%)

Day's Change

0.01 - 0.01

Trading Volume

8,489,220

Overview

Market Cap

91 Million

Shares Outstanding

9 Billion

Avg Volume

21,611,070

Avg Price (50 Days)

0.01

Avg Price (200 Days)

0.01

PE Ratio

-0.50

EPS

-0.02

Earnings Announcement

04-Aug-2025

Previous Close

0.01

Open

0.01

Day's Range

0.01 - 0.01

Year Range

0.002 - 0.019

Trading Volume

8,489,220

Price Change Highlight

1 Day Change

0.00%

5 Day Change

-9.09%

1 Month Change

42.86%

3 Month Change

-9.09%

6 Month Change

233.33%

Ytd Change

11.11%

1 Year Change

100.00%

3 Year Change

-41.18%

5 Year Change

-44.44%

10 Year Change

-93.33%

Max Change

-98.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment